Regulatory Strategy
HomeServicesRegulatory Strategy

Regulatory Strategy​

Biointelect harnesses our decades of industry experience into diverse regulatory consulting outputs across the life science product development pathway.

Our Regulatory Strategy Services

In addition to providing integrative regulatory guidance and recommendations within key milestones of our R&D Strategy and Planning, Commercialisation, and Market Access services, Biointelect’s team of regulatory affairs consultants also provides stand-alone services across all stages of the development cycle.

Biointelect has deep and wide-ranging expertise in developing and mapping a global regulatory strategy with optimal pathways and requirements for conformance.

Our extensive Australian and global network allows us to offer bespoke solutions to complement your regulatory team capabilities, ranging from strategy mapping to implementation, management and maintenance activities.  

Rectangle 63

Early Stage

In this phase, our regulatory affairs team identifies critical regulatory requirements and collaborates with you on strategy early to reduce the risk of delay in late-stage development.

We provide advice within workshops or ad-hoc to guide investment decisions, grant applications, and support trial activities to maximise each value inflection point.

We can develop a high-level product development plan to provide you with a road map and funding requirements. 

Rectangle 63

Growth Stage

This phase involves implementing a well-defined go-to-market regulatory strategy while keeping track of ever-changing global regulations and company requirements, key to commercial success.

We investigate opportunities to apply for special accelerated pathways or parallel authorisations to accelerate and expand product entry. We conduct due diligence to identify gaps or specific national requirements to understand and mitigate regulatory risk and provide recommendations for asset transfers.

Hand Heart

Late Stage

As we move closer to market, in this phase, we act as your liaison for direct engagement with regulatory agencies to drive successful product registrations, including representation at agency meetings and negotiation activities.

We help to establish a quality and regulatory framework for compliant and sustainable post-approval success. We also identify and engage with Australian sponsors for clinical trials or product registrations for international partners.

We have diverse expertise in regulatory consulting for biological medicines, vaccines, genetically modified organisms, and medical devices (including IVDs).

Our late stage regulatory consulting services include:

  • Regulatory agency liaison
  • Regulatory gap analysis and due diligence
  • Dossier compilation and submission management
  • Competitive intelligence
  • Pre-submission meetings
  • Comparable overseas regulator (COR) pathways
  • ACCESS consortium pathways
  • Priority review and abbreviated evaluation pathways
  • Provisional registration pathways
  • Clinical trial applications
  • International regulatory strategy roadmaps, including overview of timelines and costs

Why Biointelect for Regulatory Strategy?

image 31

Accessible Regulatory Expertise

Biointelect provides tailored, actionable, fit for purpose guidance for navigating complex regulatory pathways.


Currency and Reliability

Our lived experience and rich international network of senior advisors guide advice to mitigate risk and facilitate optimal clinical and commercial regulatory outcomes for novel therapeutics and technologies. 

Global Market Insights

Global Viewpoint

We harness opportunities for parallel or shared engagement with regulatory agencies to maximise impact.

Related Case Studies

Get in Touch

Wherever you are in your new product journey, Biointelect’s unique expertise across each stage of the life science value chain means we are ready to bring your innovative life science to market. 

Take the next steps in advancing healthcare for all by contacting our team of local Australian and global life science experts today.